Xylamine

    WARNING: This product is for research use only, not for human or veterinary use.

Hodoodo CAT#: H341479

CAS#: 78686-02-9

Description: Xylamine is a biochemical.


Chemical Structure

img
Xylamine
CAS# 78686-02-9

Theoretical Analysis

Hodoodo Cat#: H341479
Name: Xylamine
CAS#: 78686-02-9
Chemical Formula: C12H18ClN
Exact Mass: 211.11
Molecular Weight: 211.733
Elemental Analysis: C, 68.07; H, 8.57; Cl, 16.74; N, 6.62

Price and Availability

This product is not in stock, which may be available by custom synthesis. For cost-effective reason, minimum order is 1g (price is usually high, lead time is 2~3 months, depending on the technical challenge). Quote less than 1g will not be provided. To request quote, please email to sales @hodoodo.com or click below button.
Note: Price will be listed if it is available in the future.

Request quote for custom synthesis

Synonym: Xylamine;

IUPAC/Chemical Name: Benzenemethanamine, N-(2-chloroethyl)-N-ethyl-2-methyl-

InChi Key: XHRCFGDFESIFRG-UHFFFAOYSA-N

InChi Code: InChI=1S/C12H18ClN/c1-3-14(9-8-13)10-12-7-5-4-6-11(12)2/h4-7H,3,8-10H2,1-2H3

SMILES Code: CC1=CC=CC=C1CN(CCCl)CC

Appearance: Solid powder

Purity: >98% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility: Soluble in DMSO

Shelf Life: >2 years if stored properly

Drug Formulation: This drug may be formulated in DMSO

Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code: 2934.99.9001

More Info:

Biological target:
In vitro activity:
In vivo activity:

Preparing Stock Solutions

The following data is based on the product molecular weight 211.73 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
Formulation protocol:
In vitro protocol:
In vivo protocol:

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.
=
x
x
g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Dilution Calculator

Calculate the dilution required to prepare a stock solution.
x
=
x

1: Krysl D, Deykun K, Lambert L, Pokorny J, Mares J. Perifocal and remote blood-brain barrier disruption in cortical photothrombotic ischemic lesion and its modulation by the choice of anesthesia. J Physiol Pharmacol. 2012 Apr;63(2):127-32. PubMed PMID: 22653898.

2: Riccioni T, Leonardi F, Borsini F. Adenosine A(2A) Receptor Binding Profile of Two Antagonists, ST1535 and KW6002: Consideration on the Presence of Atypical Adenosine A(2A) Binding Sites. Front Psychiatry. 2010 Aug 6;1:22. doi: 10.3389/fpsyt.2010.00022. eCollection 2010. PubMed PMID: 21423433; PubMed Central PMCID: PMC3059644.

3: Bette M, Schlimme S, Mutters R, Menendez S, Hoffmann S, Schulz S. Influence of different anaesthetics on pro-inflammatory cytokine expression in rat spleen. Lab Anim. 2004 Jul;38(3):272-9. PubMed PMID: 15207038.

4: Villarreal CF, Kina VA, Prado WA. Participation of brainstem nuclei in the pronociceptive effect of lesion or neural block of the anterior pretectal nucleus in a rat model of incisional pain. Neuropharmacology. 2004 Jul;47(1):117-27. PubMed PMID: 15165839.

5: Pinardi G, Pelissier T, Miranda HF. Interactions in the antinociceptive effect of tramadol in mice: an isobolographic analysis. Eur J Pain. 1998;2(4):343-350. PubMed PMID: 10700329.

6: Huang Y. Inhibition of contractions by tricyclic antidepressants and xylamine in rat vas deferens. Eur J Pharmacol. 1997 May 26;327(1):41-7. PubMed PMID: 9185834.

7: Huang Y. Inhibitory effect of noradrenaline uptake inhibitors on contractions of rat aortic smooth muscle. Br J Pharmacol. 1996 Feb;117(3):533-539. PubMed PMID: 8821545; PubMed Central PMCID: PMC1909298.

8: Huang Y. 4-Aminopyridine-induced phasic contractions in rat caudal epididymis are mediated through release of noradrenaline. Eur J Pharmacol. 1995 Jul 4;280(2):231-4. PubMed PMID: 7589192.

9: Benloucif S, Bennett EL, Rosenzweig MR. Norepinephrine and neural plasticity: the effects of xylamine on experience-induced changes in brain weight, memory, and behavior. Neurobiol Learn Mem. 1995 Jan;63(1):33-42. PubMed PMID: 7663878.

10: Faraj BA, Olkowski ZL, Jackson RT. Active [3H]-dopamine uptake by human lymphocytes: correlates with serotonin transporter activity. Pharmacology. 1994 May;48(5):320-7. PubMed PMID: 8016192.

11: Liang P, Chang SS, Cheng JT. Inhibitory effect of xylamine on the uptake of [3H]dopamine into isolated striatal synaptosomes of the rats. Neurosci Lett. 1993 Apr 30;153(2):181-4. PubMed PMID: 8392155.

12: Chang TK, Cheng JT. Inhibitory effect of xylamine on the uptake of [3H]norepinephrine into primary astrocyte cultures. Brain Res. 1992 Nov 27;597(1):162-5. PubMed PMID: 1477731.

13: Nedergaard OA, Cho AK, Waggaman LA. Effects of xylamine on vascular neuroeffector transmission. J Pharmacol Exp Ther. 1992 Jul;262(1):231-7. PubMed PMID: 1625202.

14: O'Connor JJ, Kruk ZL. Fast cyclic voltammetry can be used to measure stimulated endogenous 5-hydroxytryptamine release in untreated rat brain slices. J Neurosci Methods. 1991 Jun;38(1):25-33. PubMed PMID: 1921465.

15: Howard BD, Cho AK, Zhang MB, Koide M, Lin S. Covalent labeling of the cocaine-sensitive catecholamine transporter. J Neurosci Res. 1990 Jun;26(2):149-58. PubMed PMID: 2142222.

16: Singh PK, Jones SG, Jones MM. Structural factors in the in vivo chelate mobilization of aged cadmium deposits. Environ Health Perspect. 1990 Apr;85:361-70. PubMed PMID: 2384068; PubMed Central PMCID: PMC1568338.

17: Wierenga JM, Hollingworth RM. Octopamine uptake and metabolism in the insect nervous system. J Neurochem. 1990 Feb;54(2):479-89. PubMed PMID: 2105376.

18: Dudley MW, Howard BD, Cho AK. The interaction of the beta-haloethyl benzylamines, xylamine, and DSP-4 with catecholaminergic neurons. Annu Rev Pharmacol Toxicol. 1990;30:387-403. Review. PubMed PMID: 2188573.

19: Bönisch H, Martiny-Baron G, Blum B, Michael-Hepp J. Biochemical characterization and purification of the neuronal sodium-dependent noradrenaline transporter. J Neural Transm Suppl. 1990;32:413-9. PubMed PMID: 2089105.

20: Contreras PC, Bremer ME, Rao TS. GBR-12909 and fluspirilene potently inhibited binding of [3H] (+)3-PPP to sigma receptors in rat brain. Life Sci. 1990;47(22):PL133-7. PubMed PMID: 1980329.